. Author manuscript; available in PMC: 2010 Dec 1.

Published in final edited form as: Can J Neurol Sci. 2008 May;35(2):179–184. doi: 10.1017/s031716710000860x

Table 3. Steroid treatment practices of ophthalmologists and neurologists who treated at least one patient with optic neuritis per year and completed the corresponding survey questions^*.

	All	Most	Some	None	All	Most	Some	None	P value
	Ophthalmologists n=103				Neurologists n=90
No steroid treatment	4%	43%	43%	10%	0%	17%	59%	24%	P<0.01

	Ophthalmologists n=95				Neurologists n=85
Low dose oral prednisone	1%	2%	11%	86%	2%	5%	9%	84%	P=0.68

	Ophthalmologists n=86				Neurologists n=86
High dose oral prednisone	2%	4%	28%	66%	5%	8%	32%	55%	P=0.08

	Ophthalmologists n=113				Neurologists n=99
High dose intravenous methylprednisolone	16%	22%	49%	13%	25%	39%	26%	10%	P<0.01

Not all surveyed physicians completed all questions. This is why the denominator number of ophthalmologists and neurologists varies from question to question

Table 3. Steroid treatment practices of ophthalmologists and neurologists who treated at least one patient with optic neuritis per year and completed the corresponding survey questions*.

Table 3. Steroid treatment practices of ophthalmologists and neurologists who treated at least one patient with optic neuritis per year and completed the corresponding survey questions^*.